A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab in Combination with Platinum-based Chemotherapy for the Firstline Treatment of Patients with Metastatic Squamous Non-small Cell Lung Cancer..

Project: Research

Status	Active
Effective start/end date	10/8/25 → 08/1/29

Project Details